Medicis Hit With Securities Fraud Class Action
An investor has slapped Medicis Pharmaceutical Corp. with a proposed class action, accusing the dermatological-drug maker and several of its executives of overstating profits for more than four years....To view the full article, register now.
Already a subscriber? Click here to view full article